Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure < 100 mmHg (n = 1127), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

Redução do número de internações hospitalares por asma após a implantação de programa multiprofissional de controle da asma na cidade de Londrina Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil

OBJETIVO: Avaliar a relação entre a redução do número de internações hospitalares por asma e as transformações ocorridas após a intervenção realizada no sistema de saúde de Londrina. MÉTODOS: Em 2003, houve intervenção no sistema de saúde local (Unidades de Saúde da Família). Foram adotados os seguintes passos: elaboração de protocolo baseado no III Consenso Brasileiro no Manejo da Asma, fornecimento gratuito de corticosteróides inalatórios aos pacientes, capacitação de profissionais de saúde e realização de ações educativas, especialmente para a comunidade. Foram analisadas as autorizações de internação hospitalar de pacientes de Londrina com diagnóstico único de asma entre 2002 e 2005. RESULTADOS: A média de idade foi de 14,3 ± 0,5 anos, sem predomínio de sexo. Houve redução mais acentuada do número de internações hospitalares em 2005, em comparação aos anos anteriores estudados. Verifica-se declínio mais acentuado em Unidades de Saúde da Família onde a capacitação dos profissionais ocorreu há mais tempo. O índice de internação hospitalar por asma após a intervenção (2004 e 2005)-120/100.000 habitantes-foi significativamente menor que o encontrado antes da intervenção (2002 e 2003) -178/100.000 habitantes (p < 0,01). CONCLUSÕES: A curva de internação mostrou tendência à queda após o ano de 2003, não sendo identificado outro fator, além da intervenção realizada, que justificasse os resultados obtidos. Quanto maior o tempo decorrido desde a intervenção, maior a redução do número de internações. Concluímos que a intervenção realizada no sistema de saúde local foi a responsável pelos dados apresentados.<br>OBJECTIVE: To evaluate the relationship between the reduction in the number of asthma-related hospital admissions and the changes occurring after the intervention performed in the health care system of the city of Londrina, Brazil. METHODS: In 2003, an intervention was performed in the local health care system (Family Health Clinics). The steps adopted were as follows: development of a protocol based on the III Brazilian Consensus on Asthma Management; access to free inhaled corticosteroids for patients; training of health professionals; and implementation of educational measures, especially for the community. The authorizations for hospital admissions of patients diagnosed with asthma alone between 2002 and 2005 in the city of Londrina were analyzed. RESULTS: The mean age was 14.3 ± 0.5 years, without gender predominance. The number of hospital admissions fell more markedly in 2005 than in the previous years studied. This decline was more pronounced at the Family Health Clinics where professional training occurred earlier. The post-intervention (2004-2005) rate of asthma-related hospital admissions (120/100,000 inhabitants) was significantly lower than the pre-intervention (2002-2003) rate (178/100,000 inhabitants; p < 0.01). CONCLUSIONS: The admission curve showed a tendency toward a reduction after 2003, and, aside from the intervention performed, no other factors that would explain the results obtained were identified. The rate at which the number of hospital admissions decreased was in direct proportion to the length of time elapsed since the intervention (greater decreases over time). We conclude that the intervention performed in the local health care system was responsible for the data presented

Cariogenic Microorganisms and Oral Conditions in Asthmatic Children

This study evaluated the caries risk of asthmatic patients on the basis of mutans streptococci (MS) and lactobacilli levels in saliva samples as well as the index of oral hygiene and dental caries (DMFT index). The study population was composed of 80 asthmatic children, aged 3-15 years, who use specific medication, and 80 matched, healthy control children. The parents were interviewed about oral health-related factors. The World Health Organization criteria were used for dental examinations. The Kohler and Bratthal methodology was used to detect salivary MS levels and dilutions of saliva were done for lactobacilli counting. No differences between asthma and control groups were observed for caries prevalence in children aged 3-6 and 7-10 years, except in severe cases in the younger group. However, higher caries prevalence for permanent dentition was observed in 11- to 15-year-old asthmatic children. An increased dental biofilm was observed in the asthma group, as well as salivary levels of MS. No differences were observed in levels of lactobacilli. No statistical correlations were found between medication, frequency of treatment, method of consumption and caries experience, dental biofilm and salivary levels of MS or lactobacilli. However, there was a correlation between MS levels and treatment duration. The logistic regression revealed that MS level is an important risk factor for increased caries experience. Asthma should be evaluated as a risk factor for caries experience because it can increase the levels of MS and the dental biofilm. Copyright (C) 2011 S. Karger AG, BaselNorth of Parana University (UNOPAR, Universidade Norte do Parana)National Foundation for the Development of Privately Held Institutions of Higher Education (FUNADESP, Fundacao Nacional de Desenvolvimento do Ensino Superior Particular

Left ventricular hypertrophy and QTc dispersion are predictors of long-term mortality in subjects with type 2 diabetes

Universidade Federal de São Paulo, Dept Med, Div Cardiol, São Paulo, BrazilUniv São Paulo, Dept Med, Heart Inst InCor HCFMUSP, São Paulo, BrazilUniv Fed Goias, Goiania, Go, BrazilFed Univ Para, Dept Med, Belem, PA, BrazilUniv Fed Parana, Dept Med, BR-80060000 Curitiba, Parana, BrazilUniversidade Federal de São Paulo, Dept Med, Div Cardiol, São Paulo, BrazilWeb of Scienc